| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.92B | 40.77B | 40.26B | 36.02B | 35.90B | 38.80B |
| Gross Profit | 5.01B | 4.97B | 4.97B | 4.29B | 4.85B | 5.58B |
| EBITDA | 2.46B | 2.47B | 2.49B | 2.00B | 2.64B | 3.38B |
| Net Income | 1.27B | 1.27B | 1.35B | 1.02B | 1.53B | 1.95B |
Balance Sheet | ||||||
| Total Assets | 41.77B | 42.10B | 42.49B | 40.46B | 34.08B | 32.76B |
| Cash, Cash Equivalents and Short-Term Investments | 2.68B | 1.71B | 1.84B | 1.84B | 1.56B | 2.73B |
| Total Debt | 18.57B | 19.36B | 17.07B | 15.96B | 9.25B | 9.35B |
| Total Liabilities | 26.90B | 27.03B | 28.05B | 26.62B | 20.78B | 20.61B |
| Stockholders Equity | 14.88B | 15.07B | 14.45B | 13.84B | 13.30B | 12.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.37B | -145.00M | -5.90B | -537.00M | -3.71B |
| Operating Cash Flow | 0.00 | 48.00M | 233.00M | -5.70B | 20.00M | -3.22B |
| Investing Cash Flow | 0.00 | -1.45B | -424.00M | -75.00M | -520.00M | -194.00M |
| Financing Cash Flow | 0.00 | 1.26B | 187.00M | 6.17B | -639.00M | 3.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥21.23B | 8.25 | ― | 2.97% | 22.32% | 5024.88% | |
72 Outperform | ¥21.41B | 10.44 | ― | 5.04% | 11.80% | -6.32% | |
67 Neutral | ¥18.34B | 9.55 | ― | ― | 15.30% | ― | |
65 Neutral | ¥23.72B | 7.66 | ― | 4.48% | -6.37% | -16.88% | |
65 Neutral | ¥22.41B | -39.49 | ― | 3.59% | 3.28% | -5.52% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥23.72B | 10.65 | ― | 4.18% | 5.13% | 22.57% |